KIMS Files Audited FY26 Standalone & Consolidated Financial Results
Krishna Institute of Medical Sciences Limited (KIMS) has filed its audited standalone and consolidated financial statements for the financial year ended March 31, 2026. The results were approved by the Board on May 15, 2026, and are now subject to shareholder adoption at the AGM. The company's statutory auditors have confirmed adequate internal financial controls.
This is a standard regulatory filing of audited financial results and does not contain new strategic information or significant financial performance indicators that would materially impact the company's valuation.
The announcement is a routine filing of audited financial results and audit reports, with no significant positive or negative news.
Krishna Institute of Medical Sciences Limited (KIMS) has submitted its audited standalone and consolidated financial statements for the financial year ended March 31, 2026. This filing follows up on a previous intimation dated May 15, 2026, where the Board of Directors had approved these results during their meeting on the same day. The financial statements, along with the audit reports issued by the Statutory Auditors, S.R. Batliboi & Associates LLP, are now available on the company's investor relations website. These results are subject to adoption by the shareholders at the upcoming Annual General Meeting (AGM).
The audit reports confirm that the company has adequate internal financial controls in place for both standalone and consolidated financial statements, which were operating effectively as of March 31, 2026. The auditors did not encounter any instances of audit trail tampering, and prior years' audit trails have been preserved as per statutory requirements. The reports also state that no funds were received with the understanding of indirect lending or investment to identified beneficiaries, and no dividend was declared or paid during the year by the holding company, its subsidiaries, or associate companies incorporated in India.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under annual results. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.